Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record history now shows the latest revision as v3.6.3, replacing the prior v3.6.2 in the version history.
    Difference
    0.1%
    Check dated 2026-07-04T13:12:16.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.2) was added to the study's history, and the previous revision (v3.6.0) was removed from the history, indicating a version update to the page.
    Difference
    0.1%
    Check dated 2026-06-27T07:36:22.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a note that recruitment is no longer being pursued and recorded a new record revision v3.6.0; the previous revision v3.5.5 entry was removed.
    Difference
    0.4%
    Check dated 2026-06-13T00:23:59.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The study record history shows a new revision label v3.5.5 added, replacing the prior v3.5.4.
    Difference
    0.1%
    Check dated 2026-06-05T21:48:59.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new page revision, v3.5.4, was added to the record history, replacing the previous v3.5.3 and signaling an update to the page's version metadata. This change reflects the latest build of the page rather than core content or functionality.
    Difference
    0.1%
    Check dated 2026-05-15T14:08:06.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The update changes the displayed ClinicalTrials.gov page revision number from v3.5.2 to v3.5.3, reflecting a tooling/interface release rather than a modification to the trial record data.
    Difference
    0.1%
    Check dated 2026-04-24T06:44:11.000Z thumbnail image

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.